Transcatheter aortic valve replacement (TAVR) with the Sapien 3 prosthesis achieved five-year clinical outcomes similar to surgical aortic valve replacement (SAVR).

The teams behind the ACC's National Cardiovascular Data Registry and SVS Vascular Quality Initiative will collaborate on the project.

A new analysis explored if age, numerous comorbidities, the use of CVD medication and Charleston Comorbidity Index scores can be used to predict mortality among confirmed COVID-19 patients. 

preCARDIA announced that its catheter-based system for acutely decompensated heart failure has received the FDA’s breakthrough device designation.

Protamine administration during transcatheter aortic valve replacement (TAVR) is associated with a significant reduction in life-threatening and major bleeding complications.

A higher rate of cardiac arrhythmias has been observed in hospitalized COVID-19 patients, but new research suggests there’s more behind that trend than the virus itself.

There are approximately 20,000 proteins in the human heart—and one of them, if administered as a drug, could help patients recover more quickly following a myocardial infarction.

The approval was based on data from two phase III randomized, treat-to-target studies. 

Experts agree that cardiology programs can help address the specialty's diversity problem—but what steps can be taken to make a real difference?  

Infective endocarditis is a relatively rare complication of TAVR, but the infection can be fatal when it does strike.